Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma.
Bauden, Monika
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma. [electronic resource] - BMC cancer Dec 2017 - 810 p. digital
Publication Type: Journal Article
1471-2407
10.1186/s12885-017-3834-z doi
Adult
Aged
Carcinoma, Pancreatic Ductal--metabolism
Chromatography, Liquid
Cohort Studies
Epigenesis, Genetic
Female
Gene Expression Regulation, Neoplastic
Genetic Variation
Histones--metabolism
Humans
Male
Middle Aged
Pancreatic Neoplasms--metabolism
Prognosis
Protein Processing, Post-Translational
Proteomics--methods
Survival Analysis
Tandem Mass Spectrometry
Histone profiling reveals the H1.3 histone variant as a prognostic biomarker for pancreatic ductal adenocarcinoma. [electronic resource] - BMC cancer Dec 2017 - 810 p. digital
Publication Type: Journal Article
1471-2407
10.1186/s12885-017-3834-z doi
Adult
Aged
Carcinoma, Pancreatic Ductal--metabolism
Chromatography, Liquid
Cohort Studies
Epigenesis, Genetic
Female
Gene Expression Regulation, Neoplastic
Genetic Variation
Histones--metabolism
Humans
Male
Middle Aged
Pancreatic Neoplasms--metabolism
Prognosis
Protein Processing, Post-Translational
Proteomics--methods
Survival Analysis
Tandem Mass Spectrometry